Alamar Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.87M | Sell |
32,868
-652
| -2% | -$56.9K | 1.55% | 29 |
|
|
2025
Q1 | $2.29M | Sell |
33,520
-1,286
| -4% | -$87.8K | 1.36% | 32 |
|
|
2024
Q4 | $2.71M | Sell |
34,806
-1,040
| -3% | -$80.9K | 1.48% | 27 |
|
|
2024
Q3 | $2.4M | Buy |
35,846
+11,998
| +50% | +$804K | 1.33% | 36 |
|
|
2024
Q2 | $2.7M | Buy |
+23,848
| New | +$2.7M | 1.64% | 26 |
|
|
2023
Q4 | $2.9M | Buy |
23,409
+521
| +2% | +$64.7K | 2.3% | 17 |
|
|
2023
Q3 | $2.14M | Buy |
22,888
+2,139
| +10% | +$200K | 2.02% | 21 |
|
|
2023
Q2 | $2.67M | Buy |
20,749
+214
| +1% | +$27.5K | 1.96% | 23 |
|
|
2023
Q1 | $2.39M | Buy |
20,535
+29
| +0.1% | +$3.37K | 1.99% | 20 |
|
|
2022
Q4 | $2.32M | Sell |
20,506
-140
| -0.7% | -$15.9K | 2.38% | 12 |
|
|
2022
Q3 | $1.66M | Sell |
20,646
-2,302
| -10% | -$185K | 1.87% | 20 |
|
|
2022
Q2 | $1.71M | Sell |
22,948
-860
| -4% | -$64.1K | 1.93% | 25 |
|
|
2022
Q1 | $3.05M | Sell |
23,808
-4,004
| -14% | -$512K | 2.56% | 13 |
|
|
2021
Q4 | $3.73M | Sell |
27,812
-6,112
| -18% | -$820K | 2.68% | 12 |
|
|
2021
Q3 | $4.64M | Buy |
33,924
+2,496
| +8% | +$341K | 3.59% | 5 |
|
|
2021
Q2 | $3.36M | Buy |
31,428
+1,336
| +4% | +$143K | 2.93% | 12 |
|
|
2021
Q1 | $2.7M | Buy |
30,092
+3,192
| +12% | +$287K | 2.6% | 15 |
|
|
2020
Q4 | $2.49M | Buy |
+26,900
| New | +$2.49M | 2.68% | 14 |
|